DUOX1 Silencing in Mammary Cell Alters the Response to Genotoxic Stress

Table 1

Histopathological and immunohistochemical report of breast tumors.

Patients	Histopathological report	ER (%)	PR (%)	HER-2	KI-67 (%)
1	Invasive ductal carcinoma; Grade III	Negative	Negative	Negative	10–20
2	Invasive ductal carcinoma; Grade III	Negative	Negative	Negative	10
3	Ductal carcinoma in situ	>90	20–30	Inconclusive (2+)	<5
4	Infiltrating mucinous carcinoma	90–95	90–95	—	1–5
5	Invasive ductal carcinoma; Grade III	80–90	80–90	Negative	10–15
6	Invasive ductal carcinoma; Grade II	100	90–95	Negative	1
7	Invasive ductal carcinoma; Grade II	90–95	3–5	Positive	15–20
8	Invasive ductal carcinoma; Grade III	10	Negative	Negative	60
9	Ductal carcinoma in situ	80–90	70–80	Inconclusive (2+)	5
10	Ductal carcinoma in situ	5	5	Positive	5

ER: estrogen receptor; PR: progesterone receptor; HER-2: human epidermal growth factor receptor 2; KI-67: cellular proliferation index.